Results 121 to 130 of about 36,039 (270)
472 - NUDT15 Variants Contribute to Thiopurine-Induced Myelosuppression in European Populations
, 2018 472 - NUDT15 Variants Contribute to Thiopurine-Induced Myelosuppression in European ...Gareth J Walker (18617842), James W Harrison (19228150), Nicholas A Kennedy (12221933), Harry Sokol (548882), Tariq Ahmad (198659), Mark J Daly (4951582), Claire M Bewshea (18618301), Michiel D Voskuil (19228153), Neel Heerasing (13087041), Dermot McGovern (4705741), Peter J Hendy (19177954), Jukka Koskela (5278172), Rinse K Weersma (12837922), Graham A Heap (18618349), Mike Weedon (19228156), James Goodhand (19177957) +15 morecore Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis
International Journal of Dermatology, EarlyView.Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of Simon M. Mueller, Helmut Beltraminelli, Wolf‐Henning Boehncke, Maximilian Böhm, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G. A. Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad +11 morewiley +1 more sourceAssociation of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease
, 2019 Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel ...JC Mansfield (7655168), J Andrews (9878555), K So (13447626), D Campbell (9860699), B Chaudhary (13563976), MJ Brookes (12222023), L Beaugerie (9360836), C Calvert (13563973), P Dunckley (13556404), V Annese (7776536), N Croft (13563982), H Dalal (13399341), SE Jones (15786767), M Auth (13563958), JC Barrett (7654931), R Cooney (12222140), P Bampton (13551235), T Barnes (9896162), M Delaney (13397397), H Sokol (13563943), DR Gaya (15786758), D Border (13563967), EAM Festen (15786752), P Banim (13563961), JO Lindsay (14451168), A Franke (7696745), J Beckly (13563964), S Foley (7835813), DS Rampton (15786773), D Gavin (13564000), A Bell (50744), S Cullen (11680141), P Hendy (13556296), TJ Creed (15786782), S Sebastian (12221999), M Brown (7628567), R Chaudhary (12222122), Neel Heerasing (13087041), S Bloom (13470937), A Todd (9859397), AT Cole (15786746), N Chanchlani (13556293), R Ward (7755917), I Gee (13564003), R D'Inca (13563985), G Chung-Faye (100786), S DeSilva (13563991), M Parkes (7655123), D Basude (13556350), M Schultz (834179), GA Heap (15786737), V Andersen (7776377), RK Weersma (7776320), TK Daneshmend (15786785), GJ Walker (12222002), AN Ananthakrishnan (7776374), JR Goodhand (15786776), P Seksik (13563940), S Connor (13423062), R Xavier (13563949), S Bell (7731767), CM Bewshea (15786743), FR Cummings (7655171), S Dharmasiri (13563994), M D'Amato (7776410), S Ramakrishnan (10588139), D Elphick (13556374), MA Rivas (7715147), J Fell (9872768), JW Harrison (15786734), NA Kennedy (12222005), B Colleypriest (13556332), J Halfvarson (13563925), A Dhar (12222170), S Cooper (9865766), PM Irving (11289144), AL Holden (15786779), D Das (5904266), TH Florin (15786755), AL Hart (15786761), D McGovern (13556320), RK Russell (7776491), RN Fedorak (15786749), J Koskela (13524691), F Bredin (7655117), S Babu (9878942), A Singh (7717904), M Feeney (13442370), N Direkze (13556359), MN Weedon (7655270), RCG Pollok (15786770), SM Everett (15786788), MJ Daly (7776545), K Subramaniam (9768269), P Bhandari (7711178), T Ahmad (5785727), MD Voskuil (15786740), P Ellul (13563913), CA Anderson (7696793) +98 morecore The PRIME trial: An investigator‐initiated, multicentre, phase II study of the poly(ADP‐ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)‐mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes
British Journal of Haematology, EarlyView.Rory M. Shallis, Jennifer VanOudenhove, Namrata Chandhok, Justin Watts, Deepa Jeyakumar, Daniel R. Reed, Jan Phillip Bewersdorf, Diane Durecki, Scott Boerner, Richard F. Little, Steven D. Gore, Jing Li, Xun Bao, Li Chen, Sayak Ghatak, Thomas Prebet, Ranjit S. Bindra, Amer M. Zeidan, Stephanie Halene +18 morewiley +1 more sourceANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand
Internal Medicine Journal, EarlyView.Abstract Background
Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.Andrea Henden, Lynette Chee, Julia Clark, Rachel Conyers, Julian Cooney, Richard Doocey, David Gottlieb, Tim Prestidge, Madeleine Powys, Philip Selby, Gaurav Sutrave, Eric Wong, Michelle K. Yong, Nada Hamad +13 morewiley +1 more sourceFrom infusion to pills in acute myeloid leukaemia: Reorganizing care beyond the infusion unit
British Journal of Haematology, EarlyView.Fortunato Morabito, Enrica Antonia Martino, Antonella Bruzzese, Nicola Amodio, Santino Caserta, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Ernesto Vigna, Massimo Gentile +11 morewiley +1 more sourceRuxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial
Journal of the European Academy of Dermatology and Venereology, EarlyView.In adults with moderate AD post‐TCS and ‐TCI, who may otherwise be eligible for systemic therapy, 1.5% ruxolitinib cream improved clinical signs and symptoms in the TRuE‐AD4 study. Abstract Background
In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently ...José Manuel Carrascosa, Vimal H. Prajapati, H. Chih‐ho Hong, Viktoria Eleftheriadou, Athanasios Tsianakas, Alexander A. Navarini, Ketty Peris, Eingun James Song, Raj Chovatiya, Sébastien Barbarot, Konstantin Popovic, Haq Nawaz, Qian Li, Vivek Purohit, Andreas Wollenberg +14 morewiley +1 more sourceFactors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
Cancer Management and Research, 2020 Xiaoyu Tu,1,* Ruizhe Chen,1,* Genping Huang,1 Nanjia Lu,1 Qin Chen,2 Xiaoxia Bai,1 Baohua Li1 1Department of Gynecologic Oncology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China ...Tu X, Chen R, Huang G, Lu N, Chen Q, Bai X, Li B +6 moredoaj OP035 NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations
, 2018 OP035 NUDT15 variants contribute to thiopurine-induced myelosuppression in European ...H Sokol (13563943), J Koskela (13524691), M Voskuil (19228168), G Heap (19177945), Neel Heerasing (13087041), N Kennedy (11650153), J Harrison (7119110), T Ahmad (5785727), R Weersma (19228171), C Bewshea (5785718), G Walker (564399), M Weedon (19228174), J Goodhand (13657621), M Daly (7943327), D McGovern (13556320), P Hendy (13556296) +15 morecore
